• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迷幻剂作为烟草使用障碍的一种潜在治疗方法:一项系统综述。

Psychedelics as a potential treatment for tobacco use disorder: a systematic review.

作者信息

Spoelstra S K, Schoevers R A, Venema S D, Knegtering H

机构信息

Addiction Care North Netherlands, Groningen, The Netherlands.

NHL Stenden University of Applied Sciences, Leeuwarden, The Netherlands.

出版信息

Discov Ment Health. 2024 Sep 17;4(1):37. doi: 10.1007/s44192-024-00095-0.

DOI:10.1007/s44192-024-00095-0
PMID:39289250
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11408463/
Abstract

INTRODUCTION

Despite considerable efforts, tobacco use disorder persists as a significant public health issue. The effectiveness of current smoking cessation therapies is limited, leading to a growing interest in alternative treatment approaches such as psychedelics.

AIM

The aim of this review is to evaluate the scientific evidence regarding the role of psychedelics in smoking cessation.

METHODS

To identify relevant literature on psychedelics and smoking cessation, a search was conducted in four academic literature databases PubMed, MEDLINE, PsycINFO, and Embase. Databases were searched from their inception up to March 24, 2024.

RESULTS

Out of the 1073 articles identified in databases, 8 publications (both clinical and non-clinical studies) met the inclusion criteria, of which a total of 4 publications originated from a single study. The majority of the studies focused on psilocybin (n = 7), for which supportive evidence was suggested for the treatment of tobacco use disorder. Additionally, research was conducted with other psychedelics for smoking cessation, such as ayahuasca, mescaline, peyote, lysergic acid diethylamide (LSD), lysergic acid amide (LSA) and (dimethyltryptamine (DMT), but the evidence base for these psychedelics is too small to draw definitive conclusions.

CONCLUSIONS

There is, although limited, evidence that psychedelics, in particular psilocybin, may offer a potential avenue for combating tobacco use disorder, though more research is needed to understand their effectiveness and safety fully.

摘要

引言

尽管付出了巨大努力,但烟草使用障碍仍然是一个重大的公共卫生问题。目前戒烟疗法的效果有限,这使得人们对诸如迷幻药等替代治疗方法的兴趣日益浓厚。

目的

本综述的目的是评估关于迷幻药在戒烟中作用的科学证据。

方法

为了识别有关迷幻药和戒烟的相关文献,我们在四个学术文献数据库(PubMed、MEDLINE、PsycINFO和Embase)中进行了检索。检索时间范围为各数据库建库至2024年3月24日。

结果

在数据库中识别出的1073篇文章中,有8篇出版物(包括临床和非临床研究)符合纳入标准,其中共有4篇出版物来自同一项研究。大多数研究集中在裸盖菇素(n = 7),有证据支持其用于治疗烟草使用障碍。此外,还对其他用于戒烟的迷幻药进行了研究,如死藤水、三甲氧苯乙胺、仙人球毒碱、麦角酸二乙胺(LSD)、麦角酰胺(LSA)和二甲基色胺(DMT),但这些迷幻药的证据基础过于薄弱,无法得出明确结论。

结论

虽然证据有限,但有证据表明迷幻药,尤其是裸盖菇素,可能为对抗烟草使用障碍提供一条潜在途径,不过需要更多研究来全面了解它们的有效性和安全性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d9/11408463/415f83b4d14b/44192_2024_95_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d9/11408463/415f83b4d14b/44192_2024_95_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d9/11408463/415f83b4d14b/44192_2024_95_Fig1_HTML.jpg

相似文献

1
Psychedelics as a potential treatment for tobacco use disorder: a systematic review.迷幻剂作为烟草使用障碍的一种潜在治疗方法:一项系统综述。
Discov Ment Health. 2024 Sep 17;4(1):37. doi: 10.1007/s44192-024-00095-0.
2
[Efficacy of psychedelics in psychiatry, a systematic review of the literature].[迷幻剂在精神病学中的疗效:文献系统综述]
Encephale. 2021 Aug;47(4):376-387. doi: 10.1016/j.encep.2020.12.002. Epub 2021 Apr 20.
3
Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies.报告迷幻药临床研究结果的学术期刊文章的文献计量分析。
J Psychoactive Drugs. 2023 Sep-Oct;55(4):434-444. doi: 10.1080/02791072.2022.2133757. Epub 2022 Oct 11.
4
Drug-drug interactions involving classic psychedelics: A systematic review.涉及经典迷幻剂的药物-药物相互作用:系统评价。
J Psychopharmacol. 2024 Jan;38(1):3-18. doi: 10.1177/02698811231211219. Epub 2023 Nov 20.
5
Psychedelics for treatment resistant depression: are they game changers?治疗抵抗性抑郁症的致幻剂:它们是游戏规则改变者吗?
Expert Opin Pharmacother. 2023 Sep-Dec;24(18):2117-2132. doi: 10.1080/14656566.2023.2281582. Epub 2024 Jan 5.
6
Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis.迷幻药治疗精神障碍的疗效和安全性:系统评价和荟萃分析。
Psychiatry Res. 2024 May;335:115886. doi: 10.1016/j.psychres.2024.115886. Epub 2024 Mar 28.
7
The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics.迷幻剂相关来电:对澳大利亚毒物信息中心与经典迷幻剂相关来电的分析
Clin Toxicol (Phila). 2024 Apr;62(4):242-247. doi: 10.1080/15563650.2024.2346612. Epub 2024 May 16.
8
Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies.经典迷幻剂与酒精使用障碍:人类与动物研究的系统性综述。
Addict Biol. 2022 Nov;27(6):e13229. doi: 10.1111/adb.13229.
9
Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans.聚焦于经典迷幻剂的人类代谢和代谢组学研究的现状与未来。
Biomed Pharmacother. 2023 Dec 31;169:115775. doi: 10.1016/j.biopha.2023.115775. Epub 2023 Nov 7.
10
Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.经典迷幻剂在成瘾治疗中的应用:以 psilocybin 为例治疗烟草依赖。
Curr Top Behav Neurosci. 2022;56:213-227. doi: 10.1007/7854_2022_327.

引用本文的文献

1
Comprehensive analysis of 42 psilocybin-producing fungal strains reveals metabolite diversity and species-specific clusters.对42种产生裸盖菇素的真菌菌株进行的综合分析揭示了代谢物多样性和物种特异性聚类。
Sci Rep. 2025 Apr 22;15(1):13822. doi: 10.1038/s41598-025-97710-z.

本文引用的文献

1
Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.迷幻蘑菇辅助治疗抑郁症:系统评价和荟萃分析。
Psychiatry Res. 2023 Nov;329:115531. doi: 10.1016/j.psychres.2023.115531. Epub 2023 Oct 11.
2
Impact of a Naturalistic Psychedelic Experience on Smoking: A Retrospective Survey.自然主义迷幻体验对吸烟的影响:一项回顾性调查
J Psychoactive Drugs. 2023 Nov-Dec;55(5):640-649. doi: 10.1080/02791072.2023.2227171. Epub 2023 Jun 21.
3
Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique.
迷幻药引发的神秘体验:跨学科讨论与批判
Front Psychiatry. 2023 Apr 5;14:1077311. doi: 10.3389/fpsyt.2023.1077311. eCollection 2023.
4
Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors.迷幻剂通过激活细胞内 5-HT2A 受体来促进神经可塑性。
Science. 2023 Feb 17;379(6633):700-706. doi: 10.1126/science.adf0435. Epub 2023 Feb 16.
5
Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation.优化裸盖菇素治疗的结果:参与者评估和准备的注意事项。
J Affect Disord. 2023 Apr 1;326:18-25. doi: 10.1016/j.jad.2023.01.077. Epub 2023 Jan 25.
6
Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies.经典迷幻剂与酒精使用障碍:人类与动物研究的系统性综述。
Addict Biol. 2022 Nov;27(6):e13229. doi: 10.1111/adb.13229.
7
Default Mode Network Modulation by Psychedelics: A Systematic Review.迷幻剂对默认模式网络的调制:系统综述。
Int J Neuropsychopharmacol. 2023 Mar 22;26(3):155-188. doi: 10.1093/ijnp/pyac074.
8
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.裸盖菇素辅助心理治疗与安慰剂治疗酒精使用障碍成年患者后重度饮酒日的百分比:一项随机临床试验。
JAMA Psychiatry. 2022 Oct 1;79(10):953-962. doi: 10.1001/jamapsychiatry.2022.2096.
9
Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review.迷幻剂、神秘体验与治疗效果:一项系统综述。
Front Psychiatry. 2022 Jul 12;13:917199. doi: 10.3389/fpsyt.2022.917199. eCollection 2022.
10
Psychedelic-Assisted Psychotherapy-A Systematic Review of Associated Psychological Interventions.迷幻剂辅助心理治疗——相关心理干预的系统评价
Front Psychol. 2022 Jun 10;13:887255. doi: 10.3389/fpsyg.2022.887255. eCollection 2022.